Piperazine derivatives useful for the treatment of gastrointestinal disorders

Details for Australian Patent Application No. 2005266448 (hide)

Owner Glaxo Group Limited

Inventors King, Nigel Paul; Gaiba, Alessandra; Takle, Andrew Kenneth; Witherington, Jason

Agent Davies Collison Cave

Pub. Number AU-A-2005266448

PCT Pub. Number WO2006/010629

Priority 0416844.9 28.07.04 GB; 0514029.8 08.07.05 GB

Filing date 26 July 2005

Wipo publication date 2 February 2006

International Classifications

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/4439 (2006.01)

C07D 207/24 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 295/02 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 333/08 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/10 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/010629 Priority application(s): WO2006/010629

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005266449-Compound formulations of 2-amino-1,3-propanediol compounds

2005266447-Use of K-252a and kinase inhibitors for the prevention or treatment of HMGB1-associated pathologies